Exuberance is running wild in the market and a Bank of America survey of fund managers found that optimism on risk assets has risen to the highest level in a decade. Here’s why investors may want to be cautious.
Read MoreBuffett’s Berkshire Hathaway put big bets on these 3 stocks in secret late last year, and one trader says one stock in the bunch looks like a solid bet now.
Read MoreThe global semiconductor shortage is good news for this chip stock. Here’s why.
Read MoreTrade Setup Buy Target $24.35 Sell Target $26.85 Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women’s health and endocrine diseases. The company’s lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with […]
Read MoreTrade Setup Avalon Advanced Materials Inc., together with its subsidiaries, engages in the acquisition, exploration, evaluation, and development of specialty metal and mineral properties primarily in Canada. The company focuses on exploring lithium, tantalum, cesium, indium, gallium, germanium, tin, rare earth elements, yttrium, and zirconium. Stocks found in this category are low priced stocks priced between .50 […]
Read MoreTrade Setup Phoenix Tree Holdings Limited, through its subsidiaries, leases apartments from property owners and rents them to residents and corporate clients in the People’s Republic of China. It designs, renovates, and furnishes apartments; and provides WiFi, 24/7 resident support, and common area maintenance and utilities to the residents, as well as repair and maintenance […]
Read MorePlus, last month’s GameStop saga is under the spotlight in Congress today, Walmart reported mixed earnings, and bitcoin surged above $52,000 for the first time.
Read MoreBuy Price: $80.00 or better Sell Price: TradersPro Sell Signal Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus; […]
Read MoreOver the last year, one of the best sectors of the stock market’s rally back to, and even above pre-pandemic levels has been the Materials sector. Beginning in mid-May to a peak last week, the sector had increased in value by nearly double by early January, as measured by the S&P 500 Materials Sector SPDR […]
Read More